Evidence map›Paper›PMID 31910779›Full record

ArticleJournal of the American Heart Association2020

Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery.

Tatsuya Maruhashi, Masato Kajikawa, Shinji Kishimoto, Haruki Hashimoto, Yuji Takaeko, Takayuki Yamaji, Takahiro Harada, Yiming Han, Yoshiki Aibara, Farina Mohamad Yusoff and 29 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05951894 (Flow-mediated Arterial Dilatation, Hypertension, Endothelin-1), which is not on this map. Cited by 73 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 5 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05951894 completednot on this mapstarted 2023, after this paper: background citation

Flow-mediated Arterial Dilatation, Hypertension, Endothelin-1 (ET-1) and Soluble Intercellular Adhesion Molecule (sICAM-1) in Obese Adolescents

Typeobservational_patient_registrySponsorUniversitas AirlanggaRan2023 to 2023Enrolled70ConditionsObesity, Hypertension, Adolescent Obesity
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 5 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. ENAC blockade reduces blood pressure and arterial stiffness in adults with obesity and insulin resistance.American journal of physiology. Heart and circulatory physiology · 2026
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 2 countries.

Tatsuya MaruhashiDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Masato KajikawaDivision of Regeneration and Medicine Hiroshima University Hiroshima Japan.
Shinji KishimotoDepartment of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan.
Haruki HashimotoDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Yuji TakaekoDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Takayuki YamajiDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Takahiro HaradaDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Yiming HanDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Yoshiki AibaraDepartment of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan.
Farina Mohamad YusoffDepartment of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan.
Takayuki HidakaDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Yasuki KiharaDepartment of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Kazuaki ChayamaDepartment of Gastroenterology and Metabolism Biomedical Sciences Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Ayumu NakashimaDepartment of Stem Cell Biology and Medicine Graduate School of Biomedical and Sciences Hiroshima University Hiroshima Japan.
Chikara GotoHiroshima International University Hiroshima Japan.
Hirofumi TomiyamaDepartment of Cardiology Tokyo Medical University Tokyo Japan.
Bonpei TakaseDivision of Biomedical Engineering National Defense Medical College Research Institute Tokorozawa Japan.
Takahide KohroDivision of Cardiovascular Medicine Jichi Medical University School of Medicine Tochigi Japan.
Toru SuzukiCardiovascular Medicine University of Leicester United Kingdom.
Tomoko IshizuCardiovascular Division Institute of Clinical Medicine University of Tsukuba Ibaraki Japan.
Shinichiro UedaDepartment of Clinical Pharmacology and Therapeutics University of the Ryukyu School of Medicine Okinawa Japan.
Tsutomu YamazakiClinical Research Support Center Faculty of Medicine The University of Tokyo Japan.
Tomoo FurumotoDepartment of Cardiovascular Medicine Hokkaido University Graduate School of Medicine Hokkaido Japan.
Kazuomi KarioDivision of Cardiovascular Medicine Jichi Medical University School of Medicine Tochigi Japan.
Teruo InoueDepartment of Cardiovascular Medicine Dokkyo Medical University Tochigi Japan.
Shinji KobaDivision of Cardiology Department of Medicine Showa University School of Medicine Tokyo Japan.
Kentaro WatanabeDepartment of Neurology, Hematology, Metaboism, Endocrinology and Diabetology (DNHMED) Yamagata University School of Medicine Yamagata Japan.
Yasuhiko TakemotoDepartment of Internal Medicine and Cardiology Osaka City University Graduate School of Medicine Osaka Japan.
Takuzo HanoDepartment of Medical Education and Population-Based Medicine Postgraduate School of Medicine Wakayama Medical University Wakayama Japan.
Masataka SataDepartment of Cardiovascular Medicine Institute of Health Biosciences The University of Tokushima Graduate School Tokushima Japan.
Yutaka IshibashiDepartment of General Medicine Shimane University Faculty of Medicine Izumo Japan.
Koichi NodeDepartment of Cardiovascular and Renal Medicine Saga University Saga Japan.
Koji MaemuraDepartment of Cardiovascular Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Yusuke OhyaThe Third Department of Internal Medicine University of the Ryukyus Okinawa Japan.
Taiji FurukawaDepartment of Internal Medicine Teikyo University School of Medicine Tokyo Japan.
Hiroshi ItoDepartment of Cardiovascular Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.
Hisao IkedaFaculty of Fukuoka Medical Technology Teikyo University Omuta Japan.
Akira YamashinaHiroshima International University Hiroshima Japan.
Yukihito HigashiDepartment of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan.
Hiroshima University · JPHiroshima International University · JPJichi Medical University · JPUniversity of the Ryukyus · JPDokkyo Medical University · JPHokkaido University · JPNagasaki University · JPNational Defense Medical College · JPOkayama University · JPOsaka City University · JPSaga University · JPShimane University · JPShowa University · JPTeikyo University · JPTeikyo University of Science · JPThe University of Tokyo · JPTokushima University · JPTokyo Medical University · JPUniversity of Leicester · GBUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Diagnostic criteria of flow-mediated vasodilation (FMD), an index of endothelial function, and nitroglycerin-induced vasodilation (NID), an index of vascular smooth muscle function, of the brachial artery have not been established. The purpose of this study was to propose diagnostic criteria of FMD and NID for normal endothelial function and normal vascular smooth muscle function. Methods and Results We investigated the cutoff values of FMD and NID in subjects with (risk group) and those without cardiovascular risk factors or cardiovascular diseases (no-risk group) in 7277 Japanese subjects (mean age 51.4±10.8 years) from the Flow-Mediated Dilation Japan study and the Flow-Mediated Dilatation Japan Registry study for analysis of the cutoff value of FMD and in 1764 Japanese subjects (62.2±16.1 years) from the registry of Hiroshima University Hospital for analysis of the cutoff value of NID. Receiver-operator characteristic curve analysis of FMD to discriminate subjects in the no-risk group from patients in the risk group showed that the optimal cutoff value of FMD to diagnose subjects in the no-risk group was 7.1%. Receiver-operator characteristic curve analysis of NID to discriminate subjects in the no-risk group from patients in the risk group showed that the optimal cutoff value of NID to diagnose subjects in the no-risk group was 15.6%. Conclusions We propose that the cutoff value for normal endothelial function assessed by FMD of the brachial artery is 7.1% and that the cutoff value for normal vascular smooth muscle function assessed by NID of the brachial artery is 15.6% in Japanese subjects. Clinical Trial Registration www.umin.ac.jp Unique identifiers: UMIN000012950, UMIN000012951, UMIN000012952, and UMIN000003409.

Indexed as

UltrasonographyVasodilationAdolescentAdultAgedAged, 80 and overBrachial ArteryCardiovascular DiseasesEndothelium, VascularFemaleHeart Disease Risk FactorsHumansHyperemiaJapanMaleMiddle AgedNitroglycerinVasodilator Agentsdiagnostic criteriaendothelial functionflow‐mediated vasodilationnitroglycerin‐induced vasodilationvascular smooth muscle function

Identifiers

PMID31910779
PMCPMC7033833
OpenAlexW2999036516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.